GlassScriptPhysician profile
Shelley S Byrd
NPI 1841576915
$4,805.24
in general payments reported to CMS, 2019-2025
40 companies · $993 in 2025
The $993 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,316 · 2022: $722 · 2023: $1,019 · 2024: $755 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,592 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.93 |
| Education | $174.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $555.37 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $516.51 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $440.61 | 2021-2025 | Krystexxa, Evenity, Prolia |
| Abbvie INC. | $409.97 | 2021-2025 | |
| Pfizer INC. | $407.25 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $389.86 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amarin Pharma, INC. | $220.86 | 2021-2023 | |
| Exact Sciences Corporation | $204.62 | 2023-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $200.96 | 2021-2023 | Trintellix |
| Astellas Pharma US INC | $195.84 | 2023 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $156.19 | 2021-2024 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $145.66 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.28 | 2021-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $95.85 | 2022 | |
| Merck Sharp & Dohme LLC | $77.81 | 2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.